Gilead Sciences, Inc.’s (NASDAQ:GILD) (Read Report! How GILD Noticeable Reacts on News Jerk?) investigational Tenofovir Alafenamide based single tablet HIV regimen meets 48-week primary objective in two phase 3 studies; U.S. as well as EU filings planned for 4Q2014. Share price of Gilead Sciences, Inc. (NASDAQ:GILD) climbed 3.10% to closed at $108.66 with the traded volume of 14.78 million shares as compared to the average volume of 15.17 million in last session. The 3 analysts rate its stocks at “Hold,” 10 analysts rate it at “strong buy” and 13 rate it a “Buy,” according to a recent a pool of analysts rating.
As, Lipocine Inc (NASDAQ:LPCN) (Watch Expert Views In Detail on BBRY Here) reported optimistic top-line results in its Phase 3 study of LPCN 1021 for oral testosterone replacement therapy. Lipocine persists to anticipate to file a New Drug Application with the U.S. Food and Drug Administration in the second half of 2015. As, Lipocine Inc (NASDAQ:LPCN) has traded share price of $7.23 with positive change of 38.51%. On analytic notes; diverse intension of analysts reflects as, 1 analysts rate it at “strong buy” and 1 rate it a “Buy.”
Micronet Enertec Technologies (MICT) unveiled on Wednesday that its MRM subsidiary, Micronet, has established a strategic partnership with Verizon Communications Inc. (NYSE:VZ) (In Eye of Expert, Trend Analysis after Current Fluctuation? Get Her Free Report) to make its broad line of mobile data terminals more widely available to Verizon customers, VARs, and channel partners. Verizon Communications Inc. (NYSE:VZ) settled at the price of $50.07 with positive change of 0.32% as its highest price in last session was noted at $50.15. On analysts consideration, the mean recommendation of this week is 1.9, [(Strong Buy 1.0 – 5.0 (Sell)] as compare to last week mean recommendation of 1.9, which indicates zero volatility in recommendations.
The Republic of Korea confirmed its formal selection of the Lockheed Martin Corporation (NYSE:LMT) (Get Free Highly Paid Dividend Stocks Reports) F-35A Lightning II aircraft for its F-X fighter acquisition program. In addition, declared its intent to sign the LOA between the U.S. and Korean governments for 40 F-35A Conventional Take Off and Landing variant jets with initial deliveries beginning in 2018. Lockheed Martin Corporation (NYSE:LMT) has its total average volume during previous session was 1.17 million shares with share price change of 1.16% to settled at $178.39. While in a recent pool of rating, stocks rated “Hold” by 14 analysts, only 4 analysts rate it at “strong buy” while 3 analyst rate its shares to a “Buy” security.
For latest Market Updates Subscribes Here